Request a Representative

Placement training and additional information can be given by a Paragard® representative. Select from the requests below and a representative will contact you.

(*) indicates a required field

    Information requested (select all that apply)*

    Virtual Placement Training SessionLive Placement Training SessionOrdering & ReimbursementPatient Literature & Counseling ResourcesPlacement Training ResourcesGeneral Product Information









    agree I have read and accept the Legal Notice and Privacy Notice*

    Thank you

    We have received your information and you can expect to hear from us soon.

    You may be interested in visiting our Resources page.

    Important Safety Information

    • Paragard must not be used by women who had a post-pregnancy or post-abortion uterine infection in the past 3 months; have cancer of the uterus or cervix; acute pelvic inflammatory disease (PID); an infection of the cervix; an allergy to any component (including copper); or Wilson’s disease. Continue reading

    Indication

    Paragard is a copper-containing IUS (intrauterine system) indicated for the prevention of pregnancy for up to 10 years.

    Important Safety Information

    • Paragard must not be used by women who had a post-pregnancy or post-abortion uterine infection in the past 3 months; have cancer of the uterus or cervix; acute pelvic inflammatory disease (PID); an infection of the cervix; an allergy to any component (including copper); or Wilson's disease.
    • If a woman misses her period, she must be promptly evaluated for ectopic pregnancy.
    • Possible serious complications that have been associated with IUSs are PID, embedment, perforation of the uterus, and expulsion.
    • Paragard must not be used by pregnant women as this can be life threatening and may result in loss of pregnancy or infertility.
    • Menstrual cycles may become heavier and longer with intermenstrual spotting. Bleeding may be heavier than usual at first.
    • Paragard does not protect against HIV or STIs.

    Please see accompanying Full Prescribing Information.